CCL2 and ocular melanoma: In addition, OM treatment also inhibited the pro‐inflammatory cytokine production (interluekin‐6 (IL‐6), tumor necrosis factor α (TNF‐α), and monocyte chemoattractant protein‐1 (MCP‐1)) induced by LPS in a dose‐dependent manner (Figure 3e), confirming the anti‐inflammatory activity of OM in macrophages.